What is the recommended treatment for Chlamydia infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Chlamydia Infection

For uncomplicated chlamydial infection, treat with either azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days—both are equally effective with approximately 97-98% cure rates. 1, 2

First-Line Treatment Options

Azithromycin vs. Doxycycline Decision Framework

Choose azithromycin when:

  • Patient compliance is questionable or unpredictable 3, 1
  • Patient has erratic health-care-seeking behavior 3
  • Single-dose directly observed therapy is needed 1, 2
  • Patient prefers convenience of single-dose therapy 1

Choose doxycycline when:

  • Cost is a primary concern (doxycycline is less expensive) 3, 2
  • Patient has reliable follow-through with multi-day regimens 3
  • Patient has good medication adherence history 2

Both medications demonstrate equivalent efficacy based on meta-analyses of randomized clinical trials, with microbial cure rates of 97% for azithromycin and 98% for doxycycline. 2, 4 Clinical trials showing equivalence were conducted primarily in populations with good follow-up and adherence, so azithromycin's single-dose advantage becomes more pronounced in real-world settings. 3

Alternative Treatment Regimens

Use these alternatives only when first-line options are contraindicated or not tolerated:

  • Erythromycin base 500 mg orally four times daily for 7 days 3, 2
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 3, 2
  • Ofloxacin 300 mg orally twice daily for 7 days 3, 2
  • Levofloxacin 500 mg orally once daily for 7 days 3, 2

Important caveat: Erythromycin is less efficacious than azithromycin or doxycycline, and gastrointestinal side effects frequently lead to poor compliance and treatment failure. 3, 2 Use erythromycin only when absolutely necessary.

Special Population Considerations

Pregnancy

Doxycycline and ofloxacin are absolutely contraindicated in pregnancy. 1, 5

Recommended options during pregnancy:

  • Azithromycin 1 g orally as a single dose (preferred) 1, 2
  • Amoxicillin 500 mg orally three times daily for 7 days 1, 2
  • Erythromycin base 500 mg orally four times daily for 7 days (if other options unavailable) 2, 6

Children

For children ≥8 years weighing >45 kg:

  • Azithromycin 1 g orally as a single dose OR
  • Doxycycline 100 mg orally twice daily for 7 days 1

For children ≥8 years weighing <45 kg:

  • Weight-based dosing: 2 mg/kg divided into two doses on day 1, then 1 mg/kg daily for doxycycline 5

HIV-Positive Patients

Use the same treatment regimens as HIV-negative patients—no modification needed. 2

Implementation Best Practices

Medication Administration

Dispense medications on-site whenever possible and directly observe the first dose to maximize compliance. 1, 2 This is particularly critical for azithromycin single-dose therapy, where you can ensure the entire treatment is completed. 3

Patient Instructions

  • Abstain from sexual intercourse for 7 days after single-dose azithromycin OR until completion of the entire 7-day doxycycline regimen 1, 2
  • Continue abstinence until all sex partners are treated 1, 2
  • Doxycycline should be taken with adequate fluids to reduce esophageal irritation risk 5
  • If gastric irritation occurs with doxycycline, take with food or milk (absorption is not significantly affected) 5

Partner Management

All sex partners from the previous 60 days must be evaluated, tested, and treated. 1, 2 If the patient's last sexual contact was >60 days before diagnosis, still treat the most recent partner. 1, 2 Failure to treat partners is a major pitfall leading to reinfection of the index patient. 3

Follow-Up Recommendations

Test-of-Cure

Test-of-cure is NOT recommended for patients treated with recommended regimens unless: 1, 2

  • Therapeutic compliance is questionable
  • Symptoms persist after treatment
  • Reinfection is suspected

Treatment failure is uncommon with recommended regimens, occurring in 0-3% of males and 0-8% of females. 2

Reinfection Screening

Retest women approximately 3 months after treatment due to high reinfection risk (not as a test-of-cure, but to detect new infections). 1, 2 This is particularly important given that many patients become reinfected from untreated or new partners.

Common Pitfalls to Avoid

  • Do not use erythromycin as a routine alternative—reserve it only for situations where azithromycin and doxycycline are truly contraindicated, as compliance is poor and efficacy is lower. 3, 2
  • Do not prescribe doxycycline or quinolones during pregnancy—these are teratogenic. 1, 5
  • Do not skip partner treatment—this is the leading cause of reinfection. 3, 2
  • Do not perform test-of-cure routinely—this wastes resources and is not indicated unless specific concerns exist. 1, 2
  • Do not assume compliance with 7-day regimens in high-risk populations—choose azithromycin for directly observed single-dose therapy. 3, 1

Coinfection Considerations

Presumptive treatment for chlamydia is appropriate in patients with confirmed gonococcal infection, as coinfection is common. 3 When treating both infections simultaneously, doxycycline 100 mg twice daily for 7 days covers both pathogens effectively. 3

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.